×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VOR – vor biopharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VOR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/10
12:21 pm
vor
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
Low
Report
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
12/10
12:21 pm
vor
Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Low
Report
Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
12/9
06:22 pm
vor
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
12/9
07:30 am
vor
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
High
Report
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
11/12
08:00 am
vor
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
Medium
Report
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
11/8
10:05 pm
vor
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Medium
Report
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
11/8
08:46 am
vor
Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
High
Report
Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
11/7
04:05 pm
vor
Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update
High
Report
Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
07:40 am
vor
Form 8-K Vor Biopharma Inc. For: Dec 09
High
Report
Form 8-K Vor Biopharma Inc. For: Dec 09
11/14
04:34 pm
vor
Form SC 13G/A Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
Medium
Report
Form SC 13G/A Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
11/8
04:21 pm
vor
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Chakraborty Tirtha
Medium
Report
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Chakraborty Tirtha
11/8
04:16 pm
vor
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: ANG ROBERT
Medium
Report
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: ANG ROBERT
11/8
04:16 pm
vor
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Attar Eyal C.
Medium
Report
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Attar Eyal C.
11/8
04:16 pm
vor
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Quinlan Amy
Medium
Report
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Quinlan Amy
11/7
04:02 pm
vor
Form 10-Q Vor Biopharma Inc. For: Sep 30
High
Report
Form 10-Q Vor Biopharma Inc. For: Sep 30
11/5
04:16 pm
vor
Form 4 Vor Biopharma Inc. For: Nov 01 Filed by: Quinlan Amy
Medium
Report
Form 4 Vor Biopharma Inc. For: Nov 01 Filed by: Quinlan Amy
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: